Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2019-06-27 Environmental & Social …
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2018
Environmental & Social Information Classification · 100% confidence The document is titled 'Environmental, Social and Governance Report 2018' for Uni-Bio Science Group Ltd. It contains detailed sections on environmental, social, and governance policies, performance indicators, stakeholder communication, risk management related to ESG, and a director's message focused on sustainability and corporate social responsibility. The report covers the financial year from January 1, 2018, to December 31, 2018, and follows the ESG Reporting Guide of the Hong Kong Stock Exchange. There is no indication that this is an announcement or a brief summary; rather, it is a comprehensive report on ESG matters. Therefore, the document fits the category of Environmental & Social Information (SR).
2019-06-27 English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE SIGNING OF THE LETTER OF INTENTION FOR AN EXCLUSIVE COOPERATION FRAMEWORK AGREEMENT
Capital/Financing Update Classification · 95% confidence The document is a voluntary announcement by Uni-Bio Science Group Limited regarding the signing of a non-legally binding letter of intention for an exclusive cooperation framework agreement related to a business development project. It does not contain financial statements, audit information, management changes, voting results, or any regulatory filings. It is a business update about a cooperation agreement and future plans, which fits the category of a Capital/Financing Update or business development announcement. Given the content focuses on a cooperation framework agreement and potential joint venture discussions, it aligns best with Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive information about the agreement, not just a brief notice or report publication announcement.
2019-06-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2019
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 May 2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related capital changes. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements, typical for compliance with exchange requirements. It is not an annual or interim report, earnings release, or management discussion. The document is substantive and detailed, not a brief announcement or certification. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-06-03 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 17 MAY 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement from Uni-Bio Science Group Limited regarding the poll results of their Annual General Meeting (AGM) held on 17 May 2019. It details the voting outcomes on various resolutions including adoption of financial statements, re-election of directors, re-appointment of auditors, and granting of mandates related to share issuance and repurchase. The document does not contain the full financial statements or detailed reports but rather the official voting results of the AGM. It explicitly references the AGM Notice and Circular but does not include the full reports themselves. The document length is about 5,020 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-05-17 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2019
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30 April 2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related capital changes. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements, typical for compliance with exchange rules. The document is lengthy (15,000 characters) and contains detailed tables of share capital movements, not a summary or announcement of a report. It does not fit categories like Annual Report, Earnings Release, or Capital/Financing Update specifically, but is a regulatory compliance filing about share capital movements. Therefore, the best fitting category is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories.
2019-05-07 English
VOLUNTARY ANNOUNCEMENT ON OBTAINING ZHONGGUANCUN NATIONAL INNOVATION DEMONSTRATION ZONE MAJOR FRONTLINE INNOVATIVE TECHNOLOGY COMMERCIALISATION AND INDUSTRIALISATION PROJECT SUPPORT FUNDING
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Uni-Bio Science Group Limited regarding obtaining government subsidy funding for a specific industrialisation project. It details the nature of the subsidy, the project it supports, and the impact on the company. The document is relatively short (4032 characters) and does not contain financial statements or detailed financial data. It is an announcement of a funding event rather than a full financial report or earnings release. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Capital/Financing Update in the strict sense of financial results or capital structure changes. Instead, it is a regulatory announcement informing the market about a government subsidy received, which is best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2019-04-17 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.